| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.01 | 0.9 |